Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial

Cytokine storm is the most prominent hallmark in patients with coronavirus disease 2019 (COVID-19) that stimulates the free radical storm, both of which induce an overactive immune response during viral infection. We hypothesized that owning to its radical-scavenging and anti-inflammatory properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Moslemi, Mohammadreza, Hejazian, Seyyedeh Mina, Shaddelan, Molod, Javanali, Fatemeh, Mirghaffari, Alireza, Sadeghi, Armin, Valizadeh, Hamed, Sharifi, Akbar, Haramshahi, Morteza, Ardalan, Mohammadreza, Zununi Vahed, Sepideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207828/
https://www.ncbi.nlm.nih.gov/pubmed/35723849
http://dx.doi.org/10.1007/s10787-022-01001-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207828/
https://www.ncbi.nlm.nih.gov/pubmed/35723849
http://dx.doi.org/10.1007/s10787-022-01001-2

Ejemplares similares